MRNA · Market open
$183.97
-0.29% today·exchange $183.62
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today?
Stocktwits · 14h ago
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines
Barrons.com · 20h ago
These 2 Stocks Are Bucking The Broader Market Selloff To Hit New Multi-Year Highs — Here’s What’s Driving The Enthusiasm
Stocktwits · 1d ago
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID
MarketBeat · 1d ago
6 ‘Moonshot’ Biotech Stocks That Offer Big Risks, Bigger Rewards
Barrons.com · 1d ago
Headlines from Yahoo Finance. Not investment advice.